Earnings call transcript: Motilal Oswal beats revenue estimates in Q2 2026

Motilal Oswal Financial Services reported quarterly revenue of $17.57 billion, 20.34% above the $14.60 billion forecast, while PAT rose 29% year on year to INR 718 crore; EPS was $17.68, with no consensus comparison provided. Asset and private wealth businesses grew 43% year on year and contributed 58% of operating profit, while recurring revenue reached 66% of group revenue. Despite the results, shares fell 2.69% in the immediate reaction and were reported down 4.48% at $941.95 versus the previous close of $986.10. Management expects recurring revenue and asset/private wealth growth to support FY 2027, while citing regulatory, market, hiring and new-product execution risks.

Analysis

The price reaction is a reminder that headline growth is not the same as durable earnings quality. First resolve a material data-integrity issue: the reported dollar revenue/EPS figures do not reconcile transparently with the INR financial disclosures or stated scope. Verify the exchange filing and segment bridge before using the reported beat or any valuation screen as a signal.

If the disclosed mix shift is confirmed, the potential rerating case rests on fee-bearing AUM and wealth monetization—not on AUM growth alone. Net flows, fee yield, product mix, and RM productivity determine whether that growth reaches operating profit. The risk is that hiring and distribution costs precede monetization. Likewise, carry income tied to fund hurdles and realizations may recur over time but should not be valued as a smooth annuity.

A less appreciated exposure is the balance sheet: management says the treasury book is 98% equity. That can amplify earnings and capital volatility in a drawdown, just as MTF growth links lending exposure to market activity and collateral values. Discount brokers’ commodity push is a separate structural pressure on brokerage yields, potentially limiting recovery even if volumes improve.

Days: treat the decline as an expectations reset, not proof of deteriorating fundamentals. Over 1–3 months, test active-fund flows, fee/mix, carry recognition, and wealth-margin progression. Over 6–18 months, the thesis depends on new products and maturing fund/RM cohorts scaling without disproportionate costs. The contrarian opportunity is that investors may be over-discounting recurring fees; the counterpoint is that management’s ARR label can obscure market-linked AUM, equity-book, and carry risks.

Key Decisions for Investors

• Do not trade the reported estimate beat until the official filing confirms revenue currency, period, and consolidated scope; the supplied figures are not a reliable basis for valuation.
• Watch Motilal Oswal Financial Services rather than initiating a directional position now. Reassess after verified segment revenue/profit, fee yield, net-flow data, and wealth cost-to-income trends are available.
• If those checks confirm recurring-fee growth with improving margins, consider a staged long only after price stabilization; invalidate the thesis if flows weaken for multiple reporting periods or costs rise faster than wealth/asset-management revenue.
• Track the treasury equity book and MTF collateral quality as downside indicators. A broad market selloff, rising delinquencies, or a material decline in brokerage yields would challenge the lower-cyclicality narrative.